NOVN INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Novan, Inc. Investors

BENSALEM, Pa.--()--Law Offices of Howard G. Smith continues its investigation on behalf of Novan, Inc. (“Novan” or the “Company”) (NASDAQ: NOVN) investors concerning the Company and its officers’ possible violations of federal securities laws

On January 27, 2017, the Company announced that its two “replicate” Phase 3 clinical trials for its topical acne treatment had yielded different results. The Company revealed that one trial showed statistical significance for all three co-primary endpoints and the other trial showed statistical significance for only one co-primary endpoint.

On this news, shares of Novan fell 74% to a close of $4.86 per share on January 27, 2017.

If you purchased Novan, Inc. securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Recent Stories

RSS feed for Law Offices of Howard G. Smith

Release Summary

NOVN INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Novan, Inc. Investors

Law Offices of Howard G. Smith